HOME >> MEDICINE >> NEWS
Abdominal fat decreases, insulin action improves when elderly take hormone

ts nor physicians knew who received DHEA or the placebo until the conclusion of the study.

Using highly sensitive MRI measurements of the amount of abdominal fat, the researchers found that compared with placebo, DHEA supplementation resulted in a decrease in visceral fat (within the abdomen) of 10.2 percent in the women and 7.4 percent in the men. DHEA therapy also resulted in a decrease in subcutaneous abdominal fat (below the skin surface) averaging 6 percent in both the women and the men. The researchers found no adverse effects from DHEA therapy.

At the end of the study, patients receiving DHEA had significantly lower insulin levels during oral glucose tolerance tests than at the start of the study. Their glucose levels remained unchanged, and these results indicate an improvement in insulin action. The degree of improvement in insulin action correlated closely to the amount of decrease in visceral fat.

"Among the different fat stores, visceral fat is specifically considered potent and metabolically active because its blood drains directly to the liver," Villareal says. "Fatty acids from visceral fat get deposited in the liver and other organs and then mediate the decrease in insulin action that leads to an increased risk for diabetes."

A larger study on the effects of one year of DHEA replacement is in progress, and Villareal and Holloszy are actively recruiting individuals in the 65 to 75 year age range to participate in this new study.


'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
9-Nov-2004


Page: 1 2

Related medicine news :

1. Abdominal fat indicates severity of metabolic syndrome in obese, postmenopausal women
2. Abdominal fat, a contributor to heart disease risk, is related to alcohol drinking pattern
3. Children More Likely To Have Abdominal Pain During Termtime Than School Holidays
4. Researchers discover link between insulin and Alzheimers
5. Type of weight loss surgery more effective at reducing insulin resistance
6. Heart failure patients treated for diabetes with insulin have increase in mortality
7. Antipsychotic drugs linked to insulin resistance in children
8. Continuous insulin monitoring does not raise hospital costs
9. ERI patents treatments for insulin resistance in diabetes accompanying obesity
10. U of T researchers one step closer to creating oral insulin
11. Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology:
Cached News: